Myc expression and prognosis within DLBCL molecular subtypes. (A) Myc expression by IHC in GCB and non-GCB subtypes. (B-C) EFS by Myc positivity in ER-CHOP–treated GCB (n = 17; B) and non-GCB (n = 6; C) DLBCL patients.